Profile picture

Professor Ping-Yen Liu

National Cheng Kung University Hospital, Tainan (Taiwan)
Membership: FESC Member
Follow
Biography
Dr Ping-Yen Liu is the Director and a Professor of Medicine and Institute of Clinical Medicine, College of Medicine, National Cheng Kung University (NCKU), Tainan, Taiwan. He is also a professor of Cardiology, Internal Medicine, in the NCKU Hospital. He is currently the dupty editor of the Acta Cardiologica Sinica (ACS, Impact factor 2.1 in 2020 JCR), the official Journal of Taiwan Society of Cardiology since 2012. He also co-chairs the Committee of International Affairs in the Taiwan Society of Cardiology since 2018. Dr Liu’s research work focused on the pathophysiology of cardiovascular disease, with an emphasis on dyslipidemia, thrombosis and hemostasis, platelet function, rho kinase activity, etc. Dr. Liu has published 170 peer reviewed research papers and has an h-index of 27. He actively supervises 20+ doctoral students and graduate students and clinical researchers in NCKU.
Logo ESC

Contributor content

The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan
Presentation
The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan
Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study
Presentation
Ranolazine ameliorates palmitic acid-induced insulin resistance in HL-1 cardiomyocytes by Ca2+/ CaMKII modulation: an in vitro investigation and population-based cohort study
The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension
Presentation
The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension
Highlights from FINEARTS-HF and FINE-HEART: the role of finerenone in heart failure
Presentation
Highlights from FINEARTS-HF and FINE-HEART: the role of finerenone in heart failure
Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside
Presentation
Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside
Rho kinase pathway is crucial for platelet activation in the culprit coronary artery microenvironment during an acute coronary syndrome event: a clinical and platelet ribosome profile sequencing study
Presentation
Rho kinase pathway is crucial for platelet activation in the culprit coronary artery microenvironment during an acute coronary syndrome event: a clinical and platelet ribosome profile sequencing study
CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy
Presentation
CCAAT/enhancer binding protein delta contributes to an earlier phase of pro-inflammatory response in doxorubicin related cardiomyopathy

ESC 365 is supported by